Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis-Reference-Cited by-同舟云学术

Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis

Published:2017-11-13 Issue:2 Volume:45 Page:150-157
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Wei Wenhui¹^ORCID,Anderson Peter²,Gadkari Abhijit³,Blackburn Stuart²,Moon Rachel²,Piercy James²,Shinde Shashank¹,Gomez Jorge³,Ghorayeb Eric¹

Affiliation:

1. Sanofi; New Jersey USA

2. Adelphi Real World; Cheshire UK

3. Regeneron Pharmaceuticals Inc.; New York USA

Funder

Regeneron Pharmaceuticals

Sanofi

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.14116/fullpdf

Reference38 articles.

1. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis;Kim;J Am Acad Dermatol,2016

2. The World Allergy Organization (WAO) The World Allergy Organization (WAO) White Book on Allergy 2013 Update http://www.worldallergy.org/UserFiles/file/WhiteBook2-2013-v8.pdf

3. Adult atopic dermatitis: a review;Napolitano;G Ital Dermatol Venereol,2016

4. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization;Fivenson;J Manag Care Pharm,2002

5. Burden of atopic dermatitis in Canada;Barbeau;Int J Dermatol,2006

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Burden of Atopic Dermatitis and Opportunities for Real-World Self-Monitoring;Dermatologic Clinics;2024-10

2. Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment;Dermatology and Therapy;2024-08

3. Characterization of patients with atopic dermatitis based on flare patterns and severity of disease: A Danish population‐based study;Journal of the European Academy of Dermatology and Venereology;2024-05-30

4. Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: Results from a European multi‐centre study;Journal of the European Academy of Dermatology and Venereology;2024-03-12

5. Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies;Journal of Dermatological Treatment;2024-01-31